These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 37128167

  • 1. Treatment, not delivery, of the late preterm and term fetus with supraventricular arrhythmia.
    Holmes S, Hornberger LK, Jaeggi E, Howley L, Moon-Grady AJ, Uzun O, Kaizer A, Gilicze O, Cuneo BF.
    Ultrasound Obstet Gynecol; 2023 Oct; 62(4):552-557. PubMed ID: 37128167
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].
    Jouannic JM, Delahaye S, Le Bidois J, Fermont L, Villain E, Dommergues M, Dumez Y.
    J Gynecol Obstet Biol Reprod (Paris); 2003 Jun; 32(4):338-44. PubMed ID: 12843882
    [Abstract] [Full Text] [Related]

  • 5. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
    van der Heijden LB, Oudijk MA, Manten GT, ter Heide H, Pistorius L, Freund MW.
    Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
    [Abstract] [Full Text] [Related]

  • 6. [Diagnosis and treatment of haemodynamically significant fetal tachycardia--in 33 cases].
    Pete B, Hajdú J, Papp Z.
    Orv Hetil; 2004 Dec 26; 145(52):2611-7. PubMed ID: 15724696
    [Abstract] [Full Text] [Related]

  • 7. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment.
    Uzun O, Babaoglu K, Sinha A, Massias S, Beattie B.
    Cardiol Young; 2012 Aug 26; 22(4):372-80. PubMed ID: 22008551
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.
    Miyoshi T, Maeno Y, Hamasaki T, Inamura N, Yasukochi S, Kawataki M, Horigome H, Yoda H, Taketazu M, Nii M, Hagiwara A, Kato H, Shimizu W, Shiraishi I, Sakaguchi H, Ueda K, Katsuragi S, Yamamoto H, Sago H, Ikeda T, Japan Fetal Arrhythmia Group.
    J Am Coll Cardiol; 2019 Aug 20; 74(7):874-885. PubMed ID: 31416531
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias.
    Shah A, Moon-Grady A, Bhogal N, Collins KK, Tacy T, Brook M, Hornberger LK.
    Am J Cardiol; 2012 Jun 01; 109(11):1614-8. PubMed ID: 22444730
    [Abstract] [Full Text] [Related]

  • 11. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy.
    Parilla BV, Strasburger JF, Socol ML.
    Am J Perinatol; 1996 Nov 01; 13(8):483-6. PubMed ID: 8989479
    [Abstract] [Full Text] [Related]

  • 12. Association of Fetal Atrial Flutter with Neonatal Atrioventricular Re-entry Tachycardia Involving Accessory Pathway: A Link to be Remembered.
    Tunca Sahin G, Lewis M, Uzun O.
    Pediatr Cardiol; 2021 Apr 01; 42(4):849-856. PubMed ID: 33512546
    [Abstract] [Full Text] [Related]

  • 13. Management outcome and follow-up of fetal tachycardia.
    van Engelen AD, Weijtens O, Brenner JI, Kleinman CS, Copel JA, Stoutenbeek P, Meijboom EJ.
    J Am Coll Cardiol; 1994 Nov 01; 24(5):1371-5. PubMed ID: 7930263
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia.
    Frohn-Mulder IM, Stewart PA, Witsenburg M, Den Hollander NS, Wladimiroff JW, Hess J.
    Prenat Diagn; 1995 Dec 01; 15(13):1297-302. PubMed ID: 8710768
    [Abstract] [Full Text] [Related]

  • 15. Ventriculo-atrial time interval measured on M mode echocardiography: a determining element in diagnosis, treatment, and prognosis of fetal supraventricular tachycardia.
    Jaeggi E, Fouron JC, Fournier A, van Doesburg N, Drblik SP, Proulx F.
    Heart; 1998 Jun 01; 79(6):582-7. PubMed ID: 10078085
    [Abstract] [Full Text] [Related]

  • 16. Low mortality in fetal supraventricular tachycardia: Outcomes in a 30-year single-institution experience.
    O'Leary ET, Alexander ME, Bezzerides VJ, Drogosz M, Economy KE, Friedman KG, Pickard SS, Tworetzky W, Mah DY.
    J Cardiovasc Electrophysiol; 2020 May 01; 31(5):1105-1113. PubMed ID: 32100356
    [Abstract] [Full Text] [Related]

  • 17. Atrial flutter in the perinatal age group: diagnosis, management and outcome.
    Lisowski LA, Verheijen PM, Benatar AA, Soyeur DJ, Stoutenbeek P, Brenner JI, Kleinman CS, Meijboom EJ.
    J Am Coll Cardiol; 2000 Mar 01; 35(3):771-7. PubMed ID: 10716482
    [Abstract] [Full Text] [Related]

  • 18. Flecainide versus digoxin for fetal supraventricular tachycardia: Comparison of two drug treatment protocols.
    Sridharan S, Sullivan I, Tomek V, Wolfenden J, Škovránek J, Yates R, Janoušek J, Dominguez TE, Marek J.
    Heart Rhythm; 2016 Sep 01; 13(9):1913-9. PubMed ID: 27554948
    [Abstract] [Full Text] [Related]

  • 19. Complete resolution of arrhythmia-induced hydrops fetalis in utero.
    Narayanan M, Dhuka S, Alapati S, Kauffman RP.
    BMJ Case Rep; 2020 Oct 10; 13(10):. PubMed ID: 33040036
    [Abstract] [Full Text] [Related]

  • 20. Can digoxin and sotalol therapy for fetal supraventricular tachycardia and hydrops be successful? A case report.
    Merriman JB, Gonzalez JM, Rychik J, Ural SH.
    J Reprod Med; 2008 May 10; 53(5):357-9. PubMed ID: 18567282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.